PREVIEW
New data from recent studies involving patients with acute coronary syndromes have augmented the ongoing debate over conservative versus early invasive management. Is a routine invasive strategy appropriate for patients with NSTE-ACS? In this article, Drs Carbajal and Deedwania review the results from major studies, present an evidence-based approach to the available surgical and pharmacologic options, and summarize the current status of the debate.